Erythroderma (exfoliative dermatitis). Part 1: underlying causes, clinical presentation and pathogenesis.
Journal
Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
revised:
22
02
2021
received:
31
12
2020
accepted:
22
02
2021
pubmed:
28
2
2021
medline:
23
11
2021
entrez:
27
2
2021
Statut:
ppublish
Résumé
Erythroderma (exfoliative dermatitis), first described by Von Hebra in 1868, manifests as a cutaneous inflammatory state, with associated skin barrier and metabolic dysfunctions. The annual incidence of erythroderma is estimated to be 1-2 per 100 000 population in Europe with a male preponderance. Erythroderma may present at birth, or may develop acutely or insidiously (due to progression of an underlying primary pathology, including malignancy). Although there is a broad range of diseases that associate with erythroderma, the vast majority of cases result from pre-existing and chronic dermatoses. In the first part of this two-part concise review, we explore the underlying causes, clinical presentation, pathogenesis and investigation of erythroderma, and suggest potential treatment targets for erythroderma with unknown causes.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1001-1010Subventions
Organisme : British Association of Dermatologists
ID : Undergraduate Project Award
Informations de copyright
© 2021 British Association of Dermatologists.
Références
Okoduwa C, Lambert WC, Schwartz RA et al. Erythroderma: review of a potentially life-threatening dermatosis. Indian J Dermatol 2009; 54: 1-6.
Miyashiro D, Sanches JA. Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center. Sci Rep 2020; 10: 9774.
Harper-Kirksey K. Erythroderma. In: Life-threatening rashes. (Rose E ed). Cham: Springer, 2018; 265-77.
Mistry N, Gupta A, Alavi A, Sibbald RG. A review of the diagnosis and management of erythroderma (generalized red skin). Adv Skin Wound Care 2015; 28: 228-36; quiz 237-8.
Elias PM, Williams ML, Holleran WM et al. Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism. J Lipid Res 2008; 49: 697-714.
Radner FPW, Marrakchi S, Kirchmeier P et al. Mutations in CERS3 cause autosomal recessive congenital ichthyosis in humans. PLoS Genet 2013; 9: e1003536.
Groen D, Poole DS, Gooris GS, Bouwstra JA. Is an orthorhombic lateral packing and a proper lamellar organization important for the skin barrier function? Biochim Biophys Acta 2011; 1808: 1529-37.
Pilgram GS, Vissers DC, van der Meulen H et al. Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 2001; 117: 710-17.
Singh RK, Lee KM, Ucmak D et al. Erythrodermic psoriasis: pathophysiology and current treatment perspectives. Psoriasis (Auckl) 2016; 6: 93-104.
Gandhi NA, Pirozzi G, Graham NMH. Commonality of the IL-4/IL-13 pathway in atopic diseases. Expert Rev Clin Immunol 2017; 13: 425-37.
Moy AP, Murali M, Kroshinsky D et al. Immunologic overlap of helper T-cell subtypes 17 and 22 in erythrodermic psoriasis and atopic dermatitis. JAMA Dermatol 2015; 151: 753-60.
Fung MA. The clinical and histopathologic spectrum of "dermal hypersensitivity reactions," a nonspecific histologic diagnosis that is not very useful in clinical practice, and the concept of a "dermal hypersensitivity reaction pattern". J Am Acad Dermatol 2002; 47: 898-907.
Saed G, Fivenson DP, Naidu Y, Nickoloff BJ. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sézary syndrome expresses a Th2-type profile. J Invest Dermatol 1994; 103: 29-33.
Geskin LJ, Viragova S, Stolz DB, Fuschiotti P. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. Blood 2015; 125: 2798-805.
Gao A, Gong Y, Zhu C et al. Bone marrow endothelial cell-derived interleukin-4 contributes to thrombocytopenia in acute myeloid leukemia. Haematologica 2019; 104: 1950-61.
Sigurdsson V, de Vries IJ, Toonstra J et al. Expression of VCAM-1, ICAM-1, E-selectin, and P-selectin on endothelium in situ in patients with erythroderma, mycosis fungoides and atopic dermatitis. J Cutan Pathol 2000; 27: 436-40.
Hoeger PH, Harper JI. Neonatal erythroderma: differential diagnosis and management of the “red baby”. Arch Dis Child 1998; 79: 186-91.
Dhar S, Banerjee R, Malakar R. Neonatal erythroderma: diagnostic and therapeutic challenges. Indian J Dermatol 2012; 57: 475-8.
Louhichi N, Bahloul E, Marrakchi S et al. Thyroid involvement in Chanarin-Dorfman syndrome in adults in the largest series of patients carrying the same founder mutation in ABHD5 gene. Orphanet J Rare Dis 2019; 14: 112.
Akhyani M, Ghodsi ZS, Toosi S, Dabbaghian H. Erythroderma: a clinical study of 97 cases. BMC Dermatol 2005; 5: 5.
Mathew R, Sreedevan V. Erythroderma: a clinicopathological study of 370 cases from a tertiary care center in Kerala. Indian J Dermatol Venereol Leprol 2017; 83: 625.
Scrivener Y, Cribier B, Le Coz C et al. [Erythroderma with immunoglobulin deposits along the basal membrane. Pemphigoid erythroderma?] (in French). Ann Dermatol Venereol 1998; 125: 13-17.
Bowles AA, Smirnov B. Erythrodermic psoriasis and HIV infection. N Engl J Med 2019; 380: 80.
Paparizos V, Vasalou V, Velissariou E et al. Norwegian scabies presenting as erythroderma in HIV: a case report. Infez Med 2019; 27: 332-5.
Lim PN, Fox CP, Pammi M, Patel A. Paraneoplastic erythroderma: unusual presentation secondary to diffuse large B cell lymphoma. BMJ Case Rep 2019; 12: e228412.
Leenutaphong V, Kulthanan K, Pohboon C et al. Erythroderma in Thai patients. J Med Assoc Thai 1999; 82: 743-8.
Sudho R, Hussain SB, Bellraj E et al. Clinicopathological study of exfoliative dermatitis. Indian J Dermatol Venereol Leprol 2003; 69: 30-1.
Yuan XY, Guo JY, Dang YP et al. Erythroderma: a clinical-etiological study of 82 cases. Eur J Dermatol 2010; 20: 373-7.
Rym BM, Mourad M, Bechir Z et al. Erythroderma in adults: a report of 80 cases. Int J Dermatol 2005; 44: 731-5.
Pal S, Haroon TS. Erythroderma: a clinico-etiologic study of 90 cases. Int J Dermatol 1998; 37: 104-7.